Home / Our Services / Biostatistics
Biostatistics you can defend
From study design to final analysis, our biostatisticians choose the right approach for your program and present results in the clearest way possible.
Home / Our Services / Biostatistics
From study design to final analysis, our biostatisticians choose the right approach for your program and present results in the clearest way possible.
Biostatistics is necessary for all investigational drug or device development programmes to determine the efficacy and effectiveness in clinical trials. This includes the study designs, study conduct, determining the most effective data collection points and how analysis and reporting should be performed.
Sigma-Chi biostatisticians have a desire for quality and implement the best approach to a client situation or scenario to ensure correct analysis without an over-complex process. By using the appropriate tools, we are able to demonstrate the efficacy of a drug and present the results in the clearest way possible.
Our personalized approach forms lasting relationships and enables our experts to transfer their biostatistics knowledge to our customers.
Sigma-Chi has been built around the expert knowledge and reputation across the industry of our statistical consultancy team. Originally founded as a biostatistics contract research organization (CRO), biostatistical services have always been a key component of Sigma-Chi services as part of our heritage.
Bespoke consultancy for protocol design, endpoints and estimands, so the study answers the right question.
Robust sample size and power calculations, documented for regulators and ethics committees.
Clear Statistical Analysis Plans and table shells agreed with your team before programming starts.
Study-level analysis of tables, listings and figures, with interpretation support for the CSR.
Advice for pre-clinical studies to ensure the study objective is fulfilled.
Experience across therapeutic areas and all phases of development.
Sigma-Chi has experience across a wide range of therapeutic areas and all phases of research and development. Our scientific principles will guide you throughout your trial, ensuring high-quality data with your clinical trial reporting to support your regulatory submission.
Clinical programming is a connected chain of specifications, datasets and outputs. Sigma-Chi supports every stage, and automates quality checks where it matters most.
Study data arrives from EDC systems, central labs, ePRO and other vendors, often in different formats and structures.
Raw variables are mapped to CDISC SDTM domains, with controlled terminology applied consistently across the study.
Programs convert the raw data into standard SDTM datasets that are ready for review and submission.
Analysis datasets are designed from the statistical analysis plan and table shells, with every derivation documented.
Analysis-ready datasets with derived variables, flags and full traceability back to SDTM.
Tables, listings and figures are produced for the clinical study report, DSMB reviews and regulatory submission.
Your connection to this website is encrypted. You can check its security status at any time with these free, independent services:
GoogleGoogle Safe BrowsingMalware, phishing and unsafe contentCheck → SucuriSucuri SiteCheckMalware and blacklist scanScan → 🔒 SSLSSL certificateHTTPS encryption report by SSL LabsView →We protect your data as described in our Privacy Policy.